[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"hiv-prevention-and-care\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:hiv-prevention-and-care":30},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,51],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":20,"enrollmentInfo":21,"targetDuration":4,"studyType":24,"phases":25,"briefSummary":27,"conditions":28,"keywords":33,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":45,"leadSponsor":47,"locationsCount":50},"100650042","healthmpowerment-korea-pilot-testing-the-cultural-adaptation-of-a-digital-hiv-intervention-for-men-who-have-sex-with-men-in-south-korea-100650042",false,"NCT07741123","HealthMpowerment Korea: Pilot Testing the Cultural Adaptation of a Digital HIV Intervention for Men Who Have Sex With Men in South Korea","Pilot Testing the Cultural Adaptation of a Digital HIV Intervention for Men Who Have Sex With Men in South Korea","HMP Korea","Inclusion Criteria:\n\n* Male sex assigned at birth and current male gender identity\n* Aged 18 to 35 years\n* Current residence in the Seoul Metropolitan area\n* Korean nationality\n* Self-identify as a sexual minority (e.g., gay, bisexual, queer, or other non-heterosexual identity)\n* HIV-negative or HIV-unaware serostatus\n* Report at least 1 episode of condomless anal intercourse with a male partner in the prior 6 months\n\nExclusion Criteria:\n\n* Assigned female at birth or do not currently identify as male\n* Younger than 18 or older than 35 years of age\n* Non-residence in the Seoul Metropolitan area\n* Do not hold Korean nationality\n* Do not identify as a sexual minority\n* Known HIV-positive status\n* No reported episodes of condomless anal intercourse with a male partner in the prior 6 months",true,"MALE","18 Years","35 Years",{"count":22,"type":23},50,"ESTIMATED","INTERVENTIONAL",[26],"NA","This study tests a mobile application (app) designed to support sexual health and prevent human immunodeficiency virus (HIV) among young men in South Korea. Researchers are interested to learn if the app is acceptable, easy to use, and helpful for young men who have sex with men (MSM).\n\nParticipants will complete a 15-minute online survey at the start of the study and another 15-minute survey 3 months later. Participants will be randomly assigned to 1 of 2 study groups for 3 months:\n\n1. Intervention Group: Participants receive access to the full mobile app, called Bandi. The app includes health articles, quizzes, community discussion forums, a personal sexual health log, and a clinic finder.\n2. Control Group: Participants receive access to a basic version of the app that includes informational articles and the clinic finder only.\n\nResearchers will compare both groups over 3 months to see if using the full app leads to higher rates of HIV testing and lower sexual risk behaviors.",[29,30,31,32],"HIV Infections","HIV Prevention and Care","Risk Reduction Behavior","Digital Health",[34,35,36,37],"south korea","msm","mobile app","social stigma","NOT_YET_RECRUITING","2026-07-28",{"date":41,"type":42},"2026-08-03","ACTUAL",{"date":44,"type":23},"2026-09-01",{"date":46,"type":23},"2027-06-30",{"name":48,"class":49},"Seul Ki Choi","OTHER",1,{"id":52,"slug":53,"hasResults":11,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":57,"eligibilityCriteria":58,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":59,"targetDuration":4,"studyType":24,"phases":61,"briefSummary":63,"conditions":64,"keywords":69,"overallStatus":74,"whyStopped":4,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":50},"100609717","phase-4-enhancing-prep-uptake-and-retention-among-latine-tgw-and-gbm-in-the-south-using-long-acting-injectable-prep-100609717","NCT07218211","Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP","INCLUSION - Enhancing PrEP Uptake and Retention Among Latine Transgender Women and Gay, Bisexual, and Other Men Who Have Sex With Men in the South Using Long-Acting Injectable PrEP","INCLUSION","Inclusion Criteria:\n\n* Participants must be assigned male sex at birth.\n* Report sexual activity with a someone assigned male at birth OR identify as GBM or TGW; be HIV-negative.\n* Identify as Hispanic and\u002For Latine .\n* Be able to provide informed consent in English or Spanish .\n* Be 18 years or older .\n* Weigh at least 77 lbs (35 kg) by self-reported weight.\n* Interested in PrEP and willing to undergo the study procedures.\n\nExclusion Criteria:\n\n* Individuals living with HIV.\n* Individuals assigned female sex at birth will be excluded.\n* Individuals who are currently taking oral PrEP from another source and are not willing to switch to lenacapavir for PrEP for the duration of the study will also be excluded.\n* Individuals who report a history of severe renal or hepatic disease or with clinical stigmata of either disease on physical exam as assessed by a study clinician will be excluded.\n* Individuals taking a medication with a significant interaction with lenacapavir will be excluded from the study.",{"count":60,"type":23},100,[62],"PHASE4","The purpose of this project is to test a culturally-tailored, community-delivered long-acting injectable PrEP (lenacapavir) program for Latine gay and bisexual men (GBM) and transgender women (TGW). The objective is to evaluate whether this intervention demonstrates greater persistence on lenacapavir for Latine GBM and TGW compared with what has been observed historically at the Duke PrEP Clinic.",[65,66,67,30,68],"HIV Prevention","HIV Pre-exposure Prophylaxis","HIV Prevention Program","HIV Pre-exposure Prophylaxis Use",[70,71,72,73],"Long-acting Injectable PrEP","Lenacapavir","PrEP","PrEP injections","RECRUITING","2026-01-29",{"date":77,"type":42},"2026-02-02",{"date":79,"type":42},"2026-01-13",{"date":81,"type":23},"2028-01-05",{"name":83,"class":49},"Duke University"]